Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Oxford University COSIE study (COvid-19, Social Isolation and Emotion) is an online study which asked people about their experiences during the coronavirus lockdown in late April 2020, while also using objective tests of psychological function to measure vulnerability to mental illness such as depression.

Figure 1: Oxford University COSIE study sample

COVID-19 will have long lasting effects on mental health, both directly, as a result of infection, and indirectly, as a result of isolation. There is an urgent global need to identify the best interventions to help mitigate these effects.  However, without understanding the mechanisms of risk and resilience in this unique situation it is difficult to determine the best treatments. 

The COSIE study is designed to investigate the effect of COVID-19 on mental health and wellbeing. Study leads Professor Catherine Harmer and Dr Susannah Murphy recruited a uniquely characterised sample of the population (Figure 1) that will be assessed at regular intervals over the next few months, as the global situation evolves.

 

The restrictions to our everyday lives as a result of the coronavirus pandemic have stripped away many of our usual activities that promote mental wellbeing, and we are already seeing sharp rises in anxiety and depression in the general population.  As we face an extended period of disruption to our normal lives, it is essential that we have high quality evidence to establish the effects of social isolation over time, and to identify the factors that have a positive protective effect. - Dr Susannah Murphy, Department of Psychiatry, University of Oxford.

 

2,039 participants from the UK took part in the study. After 5 weeks of lockdown some factors were identified that were associated with a greater psychological vulnerability to depression:

  • a current mental health diagnosis
  • being in an “at-risk” group for COVID-19
  • key worker status

Importantly, other factors that are protective were also identified, including:

  • moderate levels of exercise
  • regular structured activity
  • taking a statin

 

 

 

These data are really useful as they provide us with a sense of the risk and buffering factors for the mental health effects of the coronavirus pandemic.  The protective effects of taking a statin are particularly interesting, and consistent with previous evidence suggesting that statins may protect people against depression.  - Professor Catherine Harmer, Department of Psychiatry, University of Oxford.

 

The initial evidence demonstrates what factors are associated with good and bad mental health outcomes during this unique situation. By understanding what kinds of behaviours, medication and lifestyle factors play a role in risk and resilience, it is hoped that interventions and treatments can be developed that can be targeted at those who are most vulnerable to the mental health consequences of COVID-19. 

This project has been funded by the University of Oxford's COVID-19 Research Response Fund. 

 

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

No Evidence of Significant Increase in Risk of Suicide in First Months of Pandemic

COVID-19 Mental Health Suicide

A new observational study is the first to examine suicides occurring during the early phase of the COVID-19 pandemic in multiple countries and finds that suicide numbers largely remained unchanged or declined in the pandemic’s early months, however continued monitoring is needed.

Largest study to date suggests link between COVID-19 infection and subsequent mental health and neurological conditions

COVID-19 Mental Health

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates.

Opportunities for Final Goodbyes Must be Prioritised in COVID-19 Pandemic

COVID-19 Child and Adolescent Psychiatry Mental Health

Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care.

Seven in Ten Patients Hospitalised with COVID-19 Not Fully Recovered After Five Months

COVID-19 Mental Health

The majority of survivors who left hospital following COVID-19 did not fully recover five months after discharge and continued to experience negative impacts on their physical and mental health, as well as ability to work, according to results released by the PHOSP-COVID study.

Healthy Start, Happy Start Study

Child and Adolescent Psychiatry Early intervention Mental Health

Healthy Start, Happy start is a randomised controlled trial that tested the clinical- and cost-effectiveness of a brief parenting programme - Video-feedback Intervention to promote Positive Parenting and Sensitive Discipline (VIPP-SD).

Oxford Awarded Major Funding to Probe Childhood Poverty and Social Inequalities

Awards Child and adolescent Mental Health

Ground-breaking multi-disciplinary research is to be launched today by the University of Oxford into the impact of poverty and social inequalities in early childhood, thanks to major funding from the Leverhulme Trust.